相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection
Edward J. Gane et al.
GASTROENTEROLOGY (2014)
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C
Yaron Rotman et al.
GUT (2014)
Ribavirin Improves the IFN-γ Response of Natural Killer Cells to IFN-Based Therapy of Hepatitis C Virus Infection
Jens M. Werner et al.
HEPATOLOGY (2014)
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
Eric Lawitz et al.
LANCET (2014)
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Mark S. Sulkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics A Randomized Clinical Trial
Anuoluwapo Osinusi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection
Barbara Oliviero et al.
JOURNAL OF HEPATOLOGY (2013)
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Eric Lawitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Hepatitis E Virus Infection in lmmunosuppressed Patients: Natural History and Therapy
Nassim Kamar et al.
SEMINARS IN LIVER DISEASE (2013)
Ribavirin Exerts Differential Effects on Functions of Cd4+ Th1, Th2, and Regulatory T Cell Clones in Hepatitis C
Bettina Langhans et al.
PLOS ONE (2012)
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment
Federica Bozzano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C
Golo Ahlenstiel et al.
GASTROENTEROLOGY (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action
Jan Paeshuyse et al.
CURRENT OPINION IN VIROLOGY (2011)
A Randomized Trial of Peginterferon α-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B
Vincent Rijckborst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa-Dependent Manner
Golo Ahlenstiel et al.
GASTROENTEROLOGY (2010)
Altered interferon-α-signaling in natural killer cells from patients with chronic hepatitis C virus infection
Takuya Miyagi et al.
JOURNAL OF HEPATOLOGY (2010)
Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections
Barbara Oliviero et al.
GASTROENTEROLOGY (2009)
Ribavirin: Current role in the optimal clinical management of chronic hepatitis C
K. Rajender Reddy et al.
JOURNAL OF HEPATOLOGY (2009)
Antiviral action of ribavirin in chronic hepatitis C
JM Pawlotsky et al.
GASTROENTEROLOGY (2004)
Treatment with ribavirin and interferon-α reduces interferon-γ expression in patients with chronic hepatitis C
A Bergamini et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
S Crotty et al.
NATURE MEDICINE (2000)
分享论文
